Immune Landscape of Pancreatic Cancer Development and Drug Resistance : Volume 5. Dieser Artikel ist nicht verfügbar.
Sprache: Englisch
Verlag: Elsevier Science Jun 2024, 2024
- Hardcover
- Neu
Anbieter: AHA-BUCH GmbH, Einbeck, DeutschlandAHA-BUCH GmbH
AbeBooks-Verkäufer/-in seit 14. August 2006
Zustand: Neu
EUR 333,16
Artikelbeschreibung vom Verkäufer
Neuware - Immune Landscape of Pancreatic Cancer Development and Drug Resistance explores advances in immune-based therapies aimed at harnessing the power of the immune system against pancreatic cancer and rewiring tumor microenvironments to eradicate pancreatic cells. With a strong focus on the development of therapeutic methods to improve the survival rates of pancreatic cancer, this book also shows the latest trends in immune targeted approaches for pancreatic cancer treatment. In 12 chapters, the book discusses our current understanding of PC development and its various mutational and immune features and explore some of the new immune-based therapies aimed at targeting pancreatic cancer. This book is a valuable resource for health professionals, scientists and researchers, students, and all those who wish to broaden their knowledge of advances in immunotherapy in pancreatic cancer.
Bestandsnummer des Verkäufers 9780443235238
- Titel
- Immune Landscape of Pancreatic Cancer Development and Drug Resistance : Volume 5
- Autor
- Ganji Purnachandra Nagaraju
- Verlag
- Elsevier Science Jun 2024
- Veröffentlichungsjahr
- 2024
- Zustand
- Neu
- Einband
- Buch
- Sprache
- Englisch
- ISBN-10
- 0443235236
- ISBN-13
- 9780443235238
- Artikelgewicht
- 748 Gramm
- Abmessungen
- 239x193x20 mm
Immune Landscape of Pancreatic Cancer Development and Drug Resistance explores advances in immune-based therapies aimed at harnessing the power of the immune system against pancreatic cancer and rewiring tumor microenvironments to eradicate pancreatic cells. With a strong focus on the development of therapeutic methods to improve the survival rates of pancreatic cancer, this book also shows the latest trends in immune targeted approaches for pancreatic cancer treatment. In 12 chapters, the book discusses our current understanding of PC development and its various mutational and immune features and explore some of the new immune-based therapies aimed at targeting pancreatic cancer.
This book is a valuable resource for health professionals, scientists and researchers, students, and all those who wish to broaden their knowledge of advances in immunotherapy in pancreatic cancer.
„Inhaltsangabe“ gehört möglicherweise zu einer anderen Auflage dieses Titels.
Über die Autorin bzw. den Autor
Dr. Nagaraju obtained his MSc and his PhD, both in Biotechnology, from Sri Venkateswara University in Tirupati, Andhra Pradesh, India. He received his DSc from Berhampur University in Berhampur, Odisha, India. Dr. Nagaraju’s research focuses on translational projects related to gastrointestinal malignancies. He has published over 100 research papers in highly reputed international journals and has presented more than 50 abstracts at various national and international conferences. Dr. Nagaraju is author and editor of several published books for Elsevier and Springer Nature. He serves as editorial board member of several internationally recognized academic journals. Dr. Nagaraju has received several international awards including FAACC. He also holds memberships with the Association of Scientists of Indian Origin in America (ASIOA), the Society for Integrative and Comparative Biology (SICB), The Science Advisory Board, The RNA Society, The American Association for Clinical Chemistry (AACC) and the American Association of Cancer Research (AACR).
„Über diesen Titel“ gehört möglicherweise zu einer anderen Auflage dieses Titels.